Pulse Biosciences, Inc. (PLSE)

NASDAQ: PLSE · Real-Time Price · USD

35.04

+0.79 (2.31%)

At close: Jul 30, 2026, 4:00 PM EDT

35.03

-0.01 (-0.03%)

After-hours: Jul 30, 2026, 7:43 PM EDT

Pulse Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	68.32	80.74	118.04	44.37	61.14	28.61
Cash & Short-Term Investments	68.32	80.74	118.04	44.37	61.14	28.61
Cash Growth	-42.72%	-31.60%	166.06%	-27.44%	113.67%	39.75%
Accounts Receivable	0.16	0.27	-	-	-	0.06
Inventory	0.21	0.14	-	-	-	5.82
Other Current Assets	2.45	2.28	1.41	0.96	1.01	2.13
Total Current Assets	71.13	83.42	119.45	45.33	62.15	36.63
Net Property, Plant & Equipment	6.72	7.06	8.32	8.78	10.02	11.25
Other Intangible Assets	0.41	0.58	1.22	1.89	2.55	3.22
Goodwill	2.79	2.79	2.79	2.79	2.79	2.79
Other Long-Term Assets	0.58	0.69	0.68	0.37	0.37	0.37
Total Assets	81.62	94.54	132.46	59.15	77.88	54.25

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.76	2.78	1.67	1.84	1.57	2.9
Accrued Expenses	5.41	3.58	7.03	3.81	2.6	4.39
Short-Term Debt	-	-	-	-	0.92	0.44
Current Portion of Leases	1.63	1.57	1.36	1.06	0.9	0.77
Unearned Revenue	-	-	-	-	-	0.02
Total Current Liabilities	9.8	7.92	10.06	6.71	5.98	8.52
Long-Term Leases	5.53	5.96	7.54	8.09	9.14	10.04
Other Long-Term Liabilities	-	-	-	-	65	-
Total Long-Term Liabilities	5.53	5.96	7.54	8.09	74.14	10.04
Total Liabilities	15.32	13.88	17.6	14.79	80.13	18.56

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.07	0.07	0.07	0.06	0	0.03
Additional Paid-in Capital	548.09	543.87	505.3	381.22	292.42	271.86
Retained Earnings	-481.86	-463.28	-390.5	-336.92	-294.71	-236.2
Shareholders' Equity	66.3	80.66	114.86	44.36	-2.25	35.69
Total Liabilities & Equity	81.62	94.54	132.46	59.15	77.88	54.25

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	7.16	7.53	8.9	9.14	10.96	11.25
Net Cash (Debt)	61.16	73.21	109.14	35.22	50.18	17.36
Net Cash Growth	-44.75%	-32.93%	209.87%	-29.81%	189.00%	90.42%
Net Cash Per Share	0.91	1.09	1.87	0.71	1.48	0.62
Book Value	66.3	80.66	114.86	44.36	-2.25	35.69
Book Value Per Share	0.98	1.20	1.97	0.89	-0.07	1.28
Tangible Book Value	63.1	77.29	110.85	39.68	-7.59	29.68
Tangible Book Value Per Share	0.93	1.15	1.90	0.80	-0.22	1.06

SEC Filings: 10-K · 10-Q